Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Association between Guillain-Barré syndrome and Zika virus infection

We commend Van-Mai Cao-Lormeau and colleagues (April 9, p 1531)1 for their recent work. However, several elements in their study design raise concern. In epidemiological terms, sampling of all incident Guillain-Barré cases in French Polynesia in a specific time period, as done by Cao-Lormeau and colleagues, constitutes sampling from a primary study base.2 In this context, controls should be a random sample (or stratified random sample) of the entire non-case portion of the base population.2 The authors, however, restricted control group 1 to individuals with non-febrile illness.